results from a phase i study of ytb323, a novel car-t therapy in dlbcl
Published 2 years ago • 147 plays • Length 2:53Download video MP4
Download video MP3
Similar videos
-
3:43
safety and efficacy of ytb323, a car t-cell therapy, in r/r dlbcl
-
2:19
anbal-cel: updated results from phase i study of novel cd19-targeting car-t therapy
-
2:42
results from a phase i study of cc-98633 in r/r myeloma
-
1:18
results of a phase i study of sonrotoclax for the treatment of r/r waldenström’s macroglobulinemia
-
2:42
results of phase i/ii study of epcoritamab r-dhax/c in patients with r/r dlbcl eligible for autosct
-
0:43
phase i study of rapcabtagene autoleucel in patients with r/r dlbcl
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
2:43
insights into phase i/ii study assessing fixed-duration glofitamab treatment for r/r lbcl
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:40
results from a phase i/ii study of golcadomide in r/r follicular lymphoma
-
3:47
update on the guidelines for the diagnosis, grading & management of icaht following car-t therapy
-
3:05
car-t therapy in r/r dlbcl
-
2:05
the cost-effectiveness of car t-cell therapy
-
1:33
second-line car-t therapy in b-cell lymphoma
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
1:02
the use of car-t cell products in a real-world setting
-
1:29
cd5.car t-cell therapy in patients with t-cell lymphoma
-
2:49
results of a phase i trial investigating cynk-001, a placental nk-cell product, in patients with aml
-
2:13
interim analysis of phase ii study of zamto-cel in r/r dlbcl